全球创伤性脑损伤治疗市场 – 行业趋势及 2030 年预测

创伤性脑损伤治疗市场分析和规模

创伤性脑损伤治疗药物市场增长的主要驱动因素包括治疗和矫正这些损伤所需的大量外科手术。此外，各种技术创新和进步、广泛的研发活动以及为创伤性脑损伤发展而进行的大量临床试验也有望推动 2023-2030 年预测期内创伤性脑损伤治疗市场的增长。然而，在欠发达经济体中，各种个人和消费者对这种治疗缺乏认识，限制了 2023-2030 年预测期内创伤性脑损伤治疗市场的增长。此外，高昂的价格和延迟的诊断结论将在上述预测期内挑战市场增长。此外，车祸和运动造成的伤害案件不断增加，将为上述预测期内的创伤性脑损伤治疗市场创造充足的机会。

Data Bridge Market Research 分析称，2022 年全球创伤性脑损伤治疗市场规模为 34.6 亿美元，到 2030 年将飙升至 55.3 亿美元，预计预测期内复合年增长率为 6.20%。由于对药物的需求不断增长，“医院”预计将主导创伤性脑损伤治疗市场的终端用户部分。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的洞察外，Data Bridge Market Research 整理的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

创伤性脑损伤治疗市场范围和细分

Market Definition

Traumatic brain injuries treatments are among the various therapeutic methods available in the healthcare industry developed for the treatment of traumatic brain injuries of different degrees. Majorly, the treatment involves mild pharmaceuticals designed for treatment of lower grade of injuries.

Global Traumatic Brain Injuries Treatment Market Dynamics

Drivers

• Increasing cases of brain injuries

Traumatic brain injury signs and symptoms might develop after a head injury or they can sometimes take many days or weeks to manifest. There are three levels of traumatic brain injury, mild, moderate, and severe. A patient who sustains a minor injury has a temporary concussion, which in rare circumstances may result in long-lasting functional brain abnormalities. This boosts the market growth.

Due to rising cases of brain injuries by more accidents, falls, blunt traumas, and other physical damage to the brain, as well as ongoing investments made in establishment and growth of the traumatic brain injuries treatment market.

• Rising population growth

Due to growing population and rising per capita income, which has changed consumer demand for highly sophisticated and technologically advanced products and equipment, the traumatic brain injury market has been growing across all segments and geographical locations. This has served as a driving force for the market. Also, number of patients needing treatment for traumatic brain injuries has increased due to increase in vehicle accidents, sports-related injuries, falls, gunshot wounds, and injuries from domestic violence. One of the main reasons for rise in demand for brain surgery is ageing population and neurological issues they experience as they age.

• Rising number of clinical trials for Traumatic brain injuries treatment

The large number of pipeline drugs and new drug approvals is the major factor driving the global traumatic brain injury market growth. Due to the rising prevalence of traumatic brain injury (TBI), the number of drugs under development for its treatment is expanding at a significant rate. Most of the drugs that are in the last phases of development and expected to get marketing approval during the forecast period.  Furthermore, there are a few drugs in the pipeline that demonstrate a decent efficacy and safety profile. Once these drugs are affirmed, they will expand the number of products in the market, and fuel the traumatic brain injury therapeutics market size growth.

Opportunities

• Rising number of health awareness campaigns and programs

The global market for treatment of traumatic brain injuries has opportunities due to rising number of health awareness campaigns and programs that have inspired individuals to take better care of their health and to be more aware of diseases that can be brought on by using various goods. Additionally, expansion of medical facilities worldwide and financial commitments from both public and private sectors have enabled the market for treating traumatic brain injuries to expand significantly. Such increasing applications will create lucrative opportunities in the market, thereby supplementing the market growth.

Restraints/Challenges

On the other hand, factors such as high startup costs for traumatic brain injury treatment businesses, prevents many new players from entering the market. Moreover, the strict and restrictive system of laws and regulations put in place by governments of various nations also serves as a major impediment to growth of treating traumatic brain injury market. The market growth has also been hampered by general public's lack of knowledge about brain injuries and their treatments. In addition to that, some have been discouraged from receiving such treatment due to delayed results of the diagnosis.

This traumatic brain injuries treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Traumatic brain injuries treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In August 2021, Arkansas Children’s Hospital agrees to acquire TRIUX™ neo for functional brain imaging. This will help in the detection capability when diagnosing patients across a wide spectrum including epilepsy, brain tumors, traumatic brain injury, post-traumatic stress disorder, and autism.

Global Traumatic Brain Injuries Treatment Market Scope

The traumatic brain injuries treatment market is segmented on the basis of treatment, route of administration, patient age, gender, cause of injury and end users. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

• Immediate Emergency Care
• Medications
• Diuretics
• Anti-Seizure Drugs
• Coma-Inducing Drugs
• Anti-Anxiety Agent
• Anti-Depressants
• Anti-Psychotics
• Analgesic
• Anti-Convulsant
• Anti-Coagulants
• Surgery
• Clotted Blood Removal
• Repairing Skull Fractures
• Brain Bleeding Treatment
• Window Opening In Skull And Rehabilitation

Route of Administration

• Parenteral
• Oral

Patient Age

• Children
• Teenager
• Elder

Gender

• Male
• Female

Cause of Injury

• Falls
• Motor Vehicle Traffic
• Sports
• Others

End-User

• Hospitals
• Neurology Clinics
• Independent Pharmacies
• Others

Global Traumatic Brain Injuries Treatment Market Analysis/Insights

The traumatic brain injuries treatment market is analysed and market size insights and trends are provided by country, treatment, route of administration, patient age, gender, cause of injury, and end-users as referenced above.

The countries covered in the global traumatic brain injuries treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.   

North America is expected to witness positive growth due to the significant volume of target population and increasing number of individuals suffering from traumatic brain injuries in this region.

Asia-Pacific is projected to exhibit the highest growth rate during the forecast period due to the rising cases of traffic accidents and road injuries in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global traumatic brain injuries treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global traumatic brain injuries treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global traumatic brain injuries treatment market. The data is available for historic period 2015-2020.

Competitive Landscape and Global Traumatic Brain Injuries Treatment Market Share Analysis

The global traumatic brain injuries treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global traumatic brain injuries treatment market.

Some of the major players operating in the global traumatic brain injuries treatment market are:

• Zimmer Biomet (U.S.)
• Neuren Pharmaceuticals (Australia)
• Teva Pharmaceutical Industries Ltd. (Israel)
• Medicortex Finland Oy (Finland)
• AMARANTUS BIOSCIENCE HOLDINGS, INC. (U.S.)
• Stemedica Cell Technologies, Inc. (U.S.)
• BANYAN BIOMARKERS, INC. (U.S.)
• BioDirection (U.S.)
• QuesGen Systems, Inc. (U.S.)
• Neural Analytics, Inc. (U.S.)
• Oculogica, VASOPHARM (U.S.)
• Johnson & Johnson Services Inc. (U.S.)
• Smith & Nephew (U.K.)
• Stryker (U.S.)
• Medtronic (U.S.)
• Bioretec Ltd. (Finland)
• B. Braun Melsungen AG (Germany)
• Arthrex, Inc. (U.S.)
• Wright Medical Group N.V. (U.S.)
• NuVasive Inc. (U.S.)
• Advance Orthopaedic Solutions (U.S.)
• Arthrosurface (U.S.)
• CONMED 公司 (美国)

SKU-24969